Invasive mosquito species are a serious threat to the environment and human health. There are several well-known examples of the introduction of non-native mosquito species and the risk they represent. The establishment of *Culex quinquefasciatus* in Hawaii has endangered the bird fauna of the archipelago ( [@B22] ). The invasion of the African malaria vector *Anopheles gambiae s.l.* into Brazil in 1930 was followed by severe malaria epidemics during that decade ( [@B51] ).

One of the most invasive mosquito species is *Aedes aegypti* Linnaeus, 1762, which is a major vector of the dengue, urban yellow fever and chikungunya viruses. Originally from Africa, this mosquito has had a very successful expansion history. The early establishment of trade routes between Europe, Africa and the Americas in the XV century and the expansion of the slave trade decisively contributed to the first wave of geographic expansion of this species. It is believed to have invaded the Americas and Europe during the XV-XVII centuries ( [@B54] , [@B36] ). Presumably, *Ae. aegypti* reached the Asian continent only in the late XIX century ( [@B49] ). The evolution of domestic traits in a formerly sylvatic mosquito was critical for its adaptation to artificial water containers ( [@B54] ). *Ae. aegypti* is now well adapted to the domestic environment and its close association with humans allows for long distance dispersal events due to their desiccation-resistant eggs and human host availability.

In the XX century, a vast vector control program resulted in the elimination of *Ae. aegypti* from most of Central and South America ( [@B27] ). This program was interrupted in the early 1970s and the mosquitoes then began to reinvade areas from which they had been previously eliminated ( [@B27] ). By the 1990s, *Ae. aegypti* had nearly regained the geographic distribution that it held before elimination was initiated \[see [@B28] and references therein\]. This recent re-expansion of *Ae. aegypti* , combined with an intensive urban growth and an increased global movement of people and merchandise, has triggered a dramatic rise in the incidence of dengue over the past 40 years ( [@B29] ).

The most recent example of an epidemic driven by mosquito invasion is the dengue outbreak on Madeira Island (Portugal) that occurred in October 2012, with 1,891 cases (966 laboratory-confirmed) detected at the end of November 2012 ( [@B53] ). This was the first dengue epidemic in Europe since the 1920s and it occurred in a territory where *Ae. aegypti* was introduced less than a decade ago ( [@B1] ). The mosquito was first identified on Madeira Island in 2005 ( [@B39] ), with no previous records between 1977-1979 ( [@B12] ). From then on, a vector control program was implemented to reduce the mosquito's breeding sites, educate the community and eliminate the pest through the application of insecticides. Specifically, between 2005-2008, pyrethroids (tetramethrin, d-phenothrin, alpha-cypermethrin and Pybutrin^®^33, containing pyrethrins synergised with piperonyl butoxide) and organophosphate malathion were used against the adult mosquitoes with aerial spraying applications (M Melim, unpublished observations).

However, *Ae. aegypti* continued to expand throughout the island ( [@B25] ). Despite preliminary surveys suggesting a high degree of insecticide resistance ( [@B48] , [@B20] ), no information was yet available on the possible mechanisms underlying the resistance in the local *Ae. aegypti* population. Emergence of insecticide resistance is a major challenge to vector control. Knockdown resistance ( *kdr* ) results from mutations in the voltage-gated sodium channel of insects, which is the molecular target of pyrethroids and dichloro-diphenyl-trichloroethane (DDT) ( [@B50] ). Several *kdr* mutations, such as I1011V, I1011M, V1016G, V1016I and F1534C, have been reported in *Ae. aegypti* worldwide ( [@B57] )\].

Evolutionary and population genetic studies support African *Ae. aegypti* as the ancestral form of the species and populations outside of Africa belong to one of two major lineages that are associated with West or East Africa ( [@B10] , [@B41] ). Genetic studies report varying levels of population differentiation at both the local and continental scales, which is a consequence of the major demographic perturbations in *Ae. aegypti* 's recent population history ( [@B56] ). These analyses have also been applied to insular populations of *Ae. aegypti* . In the South West islands of the Indian Ocean, high levels of genetic diversity have been reported, mainly due to historical multiple origins and founder events ( [@B18] ). In the South Pacific archipelagos, the genetic structure of the *Ae. aegypti* populations was dependent on human population density and recurrent insecticide-based control, which induced repeated population bottlenecks ( [@B56] ). To date, there is no information about the geographic origin of the *Ae. aegypti* population on Madeira Island. Madeira has strong social and commercial relations with Brazil and Venezuela, mainly due to the presence of large emigrant communities of Madeira descendants in these countries. The intensive movement of people and goods between the island and these dengue-endemic countries makes them potential sources for the introduction of both *Ae. aegypti* and dengue virus (DENV) into Madeira.

In this study, we conducted a genetic analysis based on the mitochondrial DNA (mtDNA) genes \[cytochrome oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4)\] and *kdr* mutations to explore the colonisation history and current population diversity of the *Ae. aegypti* population of Madeira island. We also included samples from Brazil and Venezuela in the analysis as putative geographic sources. The implications of these results for the control of this invasive species are discussed.

MATERIALS AND METHODS
=====================

*Mosquito samples and DNA extraction* - Samples of *Ae. aegypti* were collected on Madeira Island and from two populations of Brazil and Venezuela ( [Figure](#f01){ref-type="fig"} , [Table I](#t01){ref-type="table"} ). Larvae and eggs were collected and reared to adults in an insectary under standard conditions. Adults were kept in dry, individual tubes with silica gel until molecular analyses.

Fig. 1: map showing the geographic collection sites.

TABLE ICollection data of the sampled *Aedes aegypti* populationsLocalities, countryLocalityCoordinatesYear of collectionMosquitoes analysed (n)Madeira Island, PortugalFunchal32º40'N 16º55'W200969São Paulo, BrazilBotucatu22º53'S 48º27'W201032Caracas, VenezuelaCaracas10º29'N 66º54'W201330

DNA from the Madeira Island mosquitoes was extracted using a phenol-chloroform protocol modified by [@B19] . DNA of the individuals from Brazil and Venezuela was extracted using Chelex, as described by [@B11] .

*Kdr genotyping* - *Kdr* mutations were surveyed in *Ae. aegypti* from Madeira Island, Brazil and Venezuela. Allele-specific polymerase chain reaction (PCR) was carried out to detect the V1016I mutation in the DDT/pyrethroid insecticide target site of the voltage-gated sodium channel of *Ae. aegypti* . Primers and PCR conditions are described in [@B47] . For the detection of the F1534C mutation, a tetra primer assay, as designed by [@B30] , was used. Fragments were visualised in 2% agarose gels after electrophoresis. A subset of samples was selected for sequencing and genotype confirmation. Concerning the F1534C mutation, PCR were carried out using the AaEx31P and AaEx31Q primers described in [@B30] , with the same cycling conditions of the tetra primer assay. For the V1016I mutation, the *kdr* 20f and *kdr* 21r PCR primers were described in [@B47] , with the following cycling conditions: initial denaturation step at 95ºC for 5 min, followed by 33 cycles of 95ºC for 1 min, 56ºC for 1 min, 72ºC for 1 min and a final extension of 72ºC for 10 min. The PCR products were purified with the QIAquick^®^ PCR Purification Kit (Qiagen, Hilden, Germany) and subjected to direct sequencing at STAB VIDA (Portugal). The obtained sequences were aligned and edited using BioEdit v.7.0.9. For each mutation, Hardy-Weinberg equilibrium was tested using the exact probability test in the GenePop v.1.2 software ( [@B46] ).

*mtDNA analysis* - The mitochondrial ND4 gene was amplified using the method described by Paduan and Ribolla (2008), with slight modifications, using the primers ND4f (5'-TGATTGCCTAAGGCTCATGT-3') and ND4r (5'-TTCGGCTTCCTAGTCGTTCAT-3'). The reaction was performed in a 25 µL volume containing 5 µL of 1x buffer, 2 mM MgCl~2~, 0.4 mM deoxynucleotide triphosphate (dNTP), 0.2 µM of each primer, 1.5 U of *Taq* polymerase and 1 µL of DNA template. The PCR cycling conditions included an initial denaturation step at 94ºC for 2 min, followed by 35 cycles of 94ºC for 30 s, 50ºC for 30 s, 72ºC for 1 min and a final extension of 72ºC for 5 min.

Concerning the COI gene, two different fragments were amplified. Initially, a protocol from Paduan and Ribolla (2008) was followed with few modifications. The Fly5IP (5'-GGATTATTAGGATTTATTGT-3') and Fly10IP (5'-GCCAAATAATGAAATTGTTCT-3') primers were used. PCR was performed in a 25 µL volume containing 5 µL of 1x buffer, 2 mM MgCl2, 0.4 mM dNTP, 1 µM of each primer, 1.5 U of Taq polymerase and 1 µL of DNA template diluted 1:10. As the COI fragment that was produced was too small to make good genetic comparisons with the GenBank sequences, we used another COI gene amplification protocol to obtain a larger fragment. Thus, we followed the protocol of Paupy et al. (2012), with some modifications. The COI-FOR (5'-TGTAATTGTAACAGCTCATGCA-3') and COI-REV (5'-AATGATCATAGAAGGGCTGGAC-3') primers were used. PCR was performed in a 50 µL reaction volume containing 10 µL of 1x buffer, 1.5 mM MgCl~2~, 0.2 mM dNTP, 0.3 µM of each primer, 1 U of Taq polymerase and 2 µL of DNA template. The PCR cycling conditions included an initial denaturation step at 94ºC for 2 min, followed by 35 cycles of 94ºC for 30 sec, 54ºC for 30 sec, 72ºC for 1 min and a final extension of 72ºC for 5 min. The PCR products were purified using the QIAquick^®^ PCR Purification Kit (Qiagen, Hilden, Germany) and used for direct sequencing at STAB VIDA (Portugal). The obtained sequences were aligned and edited using the BioEdit v.7.0.9 software. These sequences were compared with the reference *Ae. aegypti* gene sequences deposited in the GenBank.

RESULTS
=======

*Kdr genotyping* - Genotyping and sequencing of the voltage-gated sodium channel revealed the presence of two *kdr* mutations. One mutation was located at position 1016 (GTA to ATA) and resulted in the replacement of a valine with an isoleucine (V1016I); this mutation occurred at a low to moderate allelic frequency in the populations studied, ranging from 8% in Madeira to 23% in Venezuela ( [Table II](#t02){ref-type="table"} ). The second mutation was located at position 1534 (TTC to TGC) and resulted in the replacement of a phenylalanine with a cysteine (F1534C); this mutation occurred at high allelic frequencies in the Madeira (98%) and Venezuela (100%) populations and at a moderate frequency in the Brazil population (23%) ( [Table III](#t03){ref-type="table"} ). All of the populations were in Hardy-Weinberg equilibrium (exact test, p \> 0.05) for the two *kdr* mutations.

TABLE IIFrequency of the V1016I knockdown resistance mutation in the populations of Madeira, Brazil and Venezuela analysed in this studyPopulationMosquitoes analysed (n)V/V ^*a*^ (n)V/I ^*b*^ (n)I/I ^*c*^ (n)I ^*d*^ (%)Madeira6959910.08Brazil3227410.09Venezuela30161400.23[^3]

TABLE IIIFrequency of the F1534C knockdown resistance mutation in the populations of Madeira, Brazil and Venezuela analysed in this studyPopulationMosquitoes analysed (n)F/F ^*a*^ (n)F/C ^*b*^ (n)C/C ^*c*^ (n)C ^*d*^ (%)Madeira6502630.98Brazil30171210.23Venezuela3000301[^4]

*mtDNA analysis* - Sequences of the COI gene were retrieved from 15 specimens from Funchal, Madeira Island (GenBank accession KF909122). The alignment of 420 bp ( [@B44] ) and 764 bp ( [@B45] ) in individuals revealed the presence of a single haplotype. The COI haplotype found in the population of *Ae. aegypti* from Madeira matched several sequences, as shown in [Table IV](#t04){ref-type="table"} . The polymorphic sites of this haplotype (HCOI-Mad) are presented in [Supplementary data](#t06){ref-type="table"} with references to the published *Ae. aegypti* (Red eyes strain) sequence of COI (GenBank accession AF390098).

TABLE IVGeographical distribution of the cytochrome oxidase subunit I (COI) haplotype of *Aedes aegypti* found in Madeira IslandHaplotypeContinentCountries (localities)ReferencesBase pairs ^*a*^GenBank accessions ^*b*^COI-HMad as in Paduan and Ribolla (2008)EuropePortugal (Madeira Island)Present paper420- AmericaBrazil (Porto Velho)Paduan and Ribolla (2008)420AY851650Puerto RicoCook et al. (2006)420DQ181441AfricaWest AfricaCook et al. (2005)420AY645261West AfricaCook et al. (2005)420AY645262AsiaIndonesia, West TimorSota and Mogi (2006)420DQ397892COI-HMad as in Paupy et al. (2012)EuropePortugal (Madeira Island)Present paper763- AmericaVenezuela, MaracayPaupy et al. (2012)763JQ926701USA, FloridaPaupy et al. (2012)763JQ926684Brazil, Foz do IguaçuMousson et al. (2005)511AJ970965Brazil, Rio BrancoMousson et al. (2005)491AJ970975AsiaVietnam, Hai PhongPaupy et al. (2012)763JQ926685Thailand, Chiang MaiPaupy et al. (2012)763JQ926691CambodiaFort et al. (2012)763HQ688294Vietnam, Ho Chi Minh CityMousson et al. (2005)534AJ970968Vietnam, HanoiMousson et al. (2005)504AJ970967OceaniaFrench Polynesia, PaeaMousson et al. (2005)534AJ970972AfricaMadagascar, ToliaryDelatte et al. (2011)416HQ693081[^5]

Sequences of the ND4 gene were retrieved from 15 specimens (GenBank accession KF909123). The alignment of 376 bp revealed only one haplotype. The ND4 haplotype matched several sequences previously reported for samples from the Americas ( [Table V](#t05){ref-type="table"} ). The polymorphic sites of this haplotype (HND4-Mad) are presented in [Supplementary data](#t06){ref-type="table"} with references to the published *Ae. aegypti* complete sequence of the ND4 gene (GenBank accession DQ440274).

TABLE VGeographical distribution of the NADH dehydrogenase subunit 4 (ND4) haplotype of *Aedes aegypti* found in Madeira islandHaplotypeContinentCountries (localities)ReferencesBase pairs ^*a*^GenBank accessions ^*b*^HND4-MadEuropePortugal (Madeira island)Present paper376- AmericaPerú (Lima)da Costa-da-Silva et al. (2005)360DQ177153 Brazil (Belém, Santos, São Sebastião)Bracco et al. (2007)335DQ176842 Brazil (Compensa)Lima and Scarpassa (2009)376EU650409Brazil (Porto Velho)Paduan and Ribolla (2008)376AY906851Brazil, Represa do CiganoPaupy et al. (2012)334JQ926726 Venezuela (Maracay)Bracco et al. (2007)335DQ176842VenezuelaUrdaneta-Marquez et al. (2008) ^*c*^376Not availableGuatemala (Guatemala City)Bracco et al. (2007)335DQ176842MexicoGorrochotegui-Escalante et al. (2002)376AF334843USA (Fort Lauderdale)Bracco et al. (2007)335DQ176842USA, FloridaPaupy et al. (2012)334JQ926725[^6]

Several works have reported the presence of NUMTs (nuclear mtDNA) in the *Ae. aegypti* genome ( [@B7] , [@B31] , [@B5] ). In our study, no heterozygous sites were detected in any sequences and the observed COI and ND4 haplotypes matched sequences that were previously reported worldwide by several authors and deposited in GenBank (see [Tables IV](#t04){ref-type="table"} , [V](#t05){ref-type="table"} for references).

DISCUSSION
==========

This is the first study on the genetic variation of *Ae. aegypti* in Madeira and, to our knowledge, the first report of the F1534C *kdr* mutation in the wild mosquito populations of Brazil and Venezuela. Our results showed a very low level of mtDNA diversity, with only one haplotype for COI and ND4, as well as the presence of two important *kdr* mutations and the quasi-fixation of the F1534C mutation.

*Origin of Ae. aegypti from Madeira* - The COI haplotype found in the Madeira population was also detected in America, Africa and Asia, while the ND4 haplotype from Madeira was only reported with high frequencies in the American continent ( [Tables IV](#t04){ref-type="table"} , [V](#t05){ref-type="table"} ). Overall, these mtDNA haplotypes belong to the West African lineage of *Ae. aegypti* , as described by [@B8] and [@B41] . There are few studies using mtDNA in *Ae. aegypti* from islands ( [@B4] , [@B18] ). In spite of a general high level of COI diversity in the southwest islands of the Indian Ocean that is associated with old and repeated introductions of *Ae. aegypti* , a unique haplotype was reported in Reunion Island. The *Ae. aegypti* population was suggested to be declining on this island due to competition with the recent invader *Aedes albopictus* ( [@B18] ). Additionally, in mainland Australia, only two COI haplotypes have been identified in a bottlenecked mosquito population restricted to the northern territories, where several dengue outbreaks have occurred since the 1980s ( [@B4] ). The same study analysed a sample from Thursday Island, which is located ca. 39 km off mainland Australia; a distinct COI haplotype was found in this *Ae. aegypti* population, which exhibited an enhanced vector competence compared with the mainland populations ( [@B4] ). This study provided evidence supporting the hypothesis that island populations may develop unique traits, even with low genetic diversity. The geographic origins of *Ae. aegypti* populations have epidemiological importance, as several studies have related the origin with traits including vector competence and insecticide resistance ( [@B21] , [@B37] ).

Regarding the *kdr* mutations associated with insecticide resistance, we observed a very low frequency of the V1016I mutation in Madeira. In samples from Botucatu (Brazil) and Caracas (Venezuela), the frequency of this mutation was low (9%) and moderate (23%), respectively. In Brazil, this mutation has been reported throughout the country, with varying frequencies ranging from 5% in the state of Roraima in the north to 73% in the state of Paraná in the south and this mutation is mainly associated with intensive vector control ( [@B40] ). Specifically in the state of São Paulo, [@B3] described a significant rise in the frequency of the V1016I mutation from 2001-2011, resulting in a heterogeneous distribution within the state. In the coastal city of Santos, she reported a frequency of 83% for the V1016I mutation, while in the inland city of Bauru, the frequency was limited to 47%. In Venezuela, the frequency of V1016I ranged from 0-14% ( [@B47] ). This mutation has also been reported in Cuba, Costa Rica, Panama, Nicaragua ( [@B47] ), Mexico ( [@B47] , [@B24] ), La Martinique ( [@B38] ) and the Cayman Islands ( [@B30] ), with equal or higher V1016I frequencies than in Madeira.

On the island, a different scenario was observed for the F1534C *kdr* mutation, with almost complete fixation of the mutant allele. The same result was observed in the sample from Venezuela, with 100% of the mosquitoes homozygous for this mutation. In contrast, the sample from Brazil showed a moderate frequency (23%) of this mutation. To date, there have been a few studies of F1534C in *Ae. aegypti* populations and these studies have reported moderate to high frequencies of this mutation: 21% in Vietnam, 77% in Thailand and 68% in Cayman Islands ( [@B34] , [@B30] , [@B59] ). Moreover, the same mutation was recently described in another invasive mosquito vector, *Ae. albopictus* , which also demonstrated a high frequency (73%) ( [@B33] ). Thus, more studies are needed to assess the global distribution of the F1534C *kdr* mutation.

Considering the worldwide distribution of the mtDNA Madeira haplotypes and the frequencies of the *kdr* mutations recorded on the island, the countries that simultaneously exhibited the same mtDNA haplotypes and comparable frequencies for the two *kdr* mutations are Brazil and Venezuela. Presently, there are frequent connections between Madeira, Venezuela and Brazil, mainly due to the human migrant population. Approximately 2,800 Brazilians were estimated to live on the island in 2010 ( [@B13] ). Additionally, more than 200,000 people from Madeira live in Venezuela. This is particularly relevant considering that the island population does not exceed 250,000 inhabitants ( [@B43] ). Moreover, the DENV serotype 1, which was identified in the recent dengue outbreak on Madeira Island, was associated with viruses circulating in Colombia, Venezuela and northern Brazil ( [@B2] ). Based on our genetic data and the present human migrant flows to and from Madeira, the most likely source populations of the *Ae. aegypti* mosquitoes in Madeira were located in South America, particularly in Brazil and Venezuela. These countries are the most endemic countries for dengue in South America ( [@B58] ).

The presence of a single haplotype for both of the sequenced mtDNA *loci* (COI and ND4) provided strong evidence for a unique recent founder event during the colonisation of Madeira Island by *Ae. aegypti* mosquitoes harbouring both *kdr* mutations. Although we cannot fully rule out the possibility of two independent introductions, each harbouring a different *kdr* mutation, this hypothesis is unlikely given the mtDNA monomorphic haplotype composition. Furthermore, the two *kdr* mutations may also be present in a single VGSC haplotype. Additional genetic analysis involving more polymorphic markers is required to further refine the geographic origin, colonisation patterns and local genetic structure of this expanding island population.

*Implications for vector control* - The current study revealed the presence of two *kdr* mutations in the dengue vector *Ae. aegypti* from Madeira Island and these mutations were likely previously present in the invading mosquitoes. These mutations may have affected the vector control programs initiated in 2005 and the application of insecticides has been shown to be ineffective ( [@B48] , [@B20] ), leading to the continuous expansion of the mosquito population throughout the southern part of the island and the recent dengue outbreak in 2012. In Brazil, where pyrethroids were introduced for dengue control in 2001 ( [@B9] ), pyrethroid resistance was soon detected ( [@B17] ), followed by the subsequent spread of the V1016I *kdr* mutation throughout most of the country in less than five years ( [@B40] , [@B6] ). Nonetheless, the use of insecticides remains the main method for controlling and reducing mosquito populations in emergencies, such as outbreaks. In Madeira, although insecticidal application for vector control was suspended between 2008 and the recent dengue outbreak, the selective pressure for insecticide resistance has been maintained through the use of household insecticides (IASAÚDE 2012). Therefore, the spread of the recently introduced insecticide-resistant *Ae. aegypti* population is very likely, which could compromise future vector control measures. We recommend the continuous monitoring of Madeira's *Ae. aegypti* population, as well as further studies involving samples from future years, to assess the local evolution of the *kdr* mutations and eventual introduction of the mosquitoes from other geographic regions to the island.

Supplementary data
==================

Mitochondrial DNA \[cytochrome oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4)\] haplotypes recorded in *Aedes aegypti* population from Madeira IslandND4 ^*a*^666666777888889991113495671358937835862332107581364Reference sequenceCAACCCTCGCGCGATAAHND4-MadTGTTTTCTATATATCCCCOI ^*a*^00000000000001111 22224555666671122 0778901416798137973658790895900150Reference sequenceGTCGGGGCAGCTCCCTGCOI as Paupy et al. (2012)ACTAAAATGATCT\-\-\--COI as Paduan and Ribolla (2008)\-\-\-\-\-\-\-\-\-\-\-\--TTCA[^7]

Mitochondrial DNA \[cytochrome oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4)\] haplotypes recorded in *Aedes aegypti* population from Madeira IslandND4 ^*a*^666666777888889991113495671358937835862332107581364Reference sequenceCAACCCTCGCGCGATAAHND4-MadTGTTTTCTATATATCCCCOI ^*a*^00000000000001111 22224555666671122 0778901416798137973658790895900150Reference sequenceGTCGGGGCAGCTCCCTGCOI as Paupy et al. (2012)ACTAAAATGATCT\-\-\--COI as Paduan and Ribolla (2008)\-\-\-\-\-\-\-\-\-\-\-\--TTCA[^8]
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[^3]: *a* : number of individuals homozygous for the susceptible-associated allele; *b* : number of heterozygous individuals; *c* : number of individuals homozygous for the resistant-associated allele; *d* : allele frequency for the resistant-associated allele. Of the total 131 individuals genotyped, 35 were confirmed by sequencing. I: isoleucine; V: valine.

[^4]: *a* : number of homozygous susceptible individuals; *b* : number of heterozygous individuals; *c* : number of homozygous resistant individuals; *d* : resistance allele frequency in the population. Of the total 125 individuals genotyped, four were confirmed by sequencing. C: cysteine; F: phenylalanine.

[^5]: *a* : number of base pairs matching the COI sequence of Madeira Island; *b* : list of GenBank accessions, the corresponding references and places of origin for COI sequences matching the haplotypes of *Ae. aegypti* found in Madeira island.

[^6]: *a* : number of base pairs matching the ND4 sequence of Madeira Island; *b* : list of GenBank accessions, the corresponding references and places of origin for ND4 sequences matching the haplotypes of *Ae. aegypti* found in Madeira island; *c* : sequences supplied by W Black IV.

[^7]: *a* : only polymorphic positions are shown and these are numbered with reference to the published *Ae. aegypti* (red eyes strain) sequence of COI, GenBank accession AF390098 and *Ae. aegypti* complete sequence of the ND4, GenBank accession DQ440274.

[^8]: *a* : only polymorphic positions are shown and these are numbered with reference to the published *Ae. aegypti* (red eyes strain) sequence of COI, GenBank accession AF390098 and *Ae. aegypti* complete sequence of the ND4, GenBank accession DQ440274.
